Imagine facing surgery for a serious injury, only to find that the pain relief options come with risks of addiction and mental health struggles. For many orthopedic trauma patients, this is a reality. Pain management is crucial, but the high rates of depression and post-traumatic stress disorder make recovery even more challenging. This clinical trial is testing ketamine, a drug typically used as an anesthetic, to see if it can help. Patients will receive either ketamine or standard anesthesia during their surgery. The study will track their pain levels and mental health, focusing on how ketamine affects pain, opioid use, and symptoms of depression and PTSD. If ketamine proves effective, it could offer a new way to support recovery, reducing reliance on opioids and addressing mental health issues. However, it’s important to remember that this research is still in progress, and results will take time. The hope is that ketamine might not only ease physical pain but also help heal emotional wounds, paving the way for a better recovery experience for many patients.
Ketamine in Orthopedic Trauma: Potential to Reduce Pain and Opioid UseCould Ketamine Be the Key to Easing Pain and Healing Minds After Surgery?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This ongoing Phase 4 clinical trial, sponsored by Texas Tech University Health Sciences Center, aims to evaluate the efficacy of intraoperative ketamine in improving recovery outcomes for adults undergoing orthopedic trauma surgery. The study enrolls 90 participants, who are randomly assigned to receive either a single dose of ketamine or standard general anesthesia during surgery. The primary endpoint is postoperative pain intensity, assessed using the Visual Analog Scale (VAS). Secondary endpoints include opioid consumption, as well as mental health outcomes measured by the PHQ-9 for depression and PCL-5 for PTSD. Participants' opioid prescriptions will be monitored through electronic medical records, and follow-up assessments will occur at multiple time points up to 6 months post-surgery. While ketamine is known for its anesthetic properties, it may offer additional benefits in reducing acute pain, decreasing opioid requirements, and improving depressive symptoms. The study's findings could inform new approaches to managing both physical and psychological recovery in this patient population. Safety and adverse event data will be collected, though specific statistics and outcomes are not yet available.